Post-approval studies (Phase 4)Study completedNCT02505477
What this trial is testing
Treatment of Cognitive and Negative Symptoms in Schizophrenia With N-acetylcysteine
Who this might be right for
SchizophreniaCognitive DeficitsSchizophrenia; Negative Type
University of California, Los Angeles 51